DURAClone IM Phenotyping Basic Citations

The following scientific literature references describe clinical research uses of of the listed products for immunological biomarker assessment and discovery purposes. These products are for research use only and are not labeled for diagnostic use.

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.

Eskandary F, Dürr M, Budde K, Doberer K, Reindl-Schwaighofer R, Waiser J, Wahrmann M, Regele H, Spittler A, Lachmann N, Firbas C, Mühlbacher J, Bond G, Halloran PF, Chong E, Jilma B, Böhmig GA. Trials. 2019 Jan 11;20(1):37. doi: 10.1186/s13063-018-3158-6. 


Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer.

Holl EK, Frazier VN, Landa K, Beasley GM, Hwang ES, Nair SK. Front Immunol. 2019 Jul 31;10:1767. doi: 10.3389/fimmu.2019.01767. eCollection 2019. 


Gravitational stress during parabolic flights reduces the number of circulating innate and adaptive leukocyte subsets in human blood.

Stervbo U, Roch T, Kornprobst T, Sawitzki B, Grütz G, Wilhelm A, Lacombe F, Allou K, Kaymer M, Pacheco A, Vigne J, Westhoff TH, Seibert FS, Babel N. PLoS One. 2018 Nov 14;13(11):e0206272. doi: 10.1371/journal.pone.0206272. eCollection 2018.


Preliminary Study of the Effect of Stereotactic Body Radiotherapy (SBRT) on the Immune System in Lung Cancer Patients Unfit for Surgery: Immunophenotyping Analysis.

Arturo Navarro-Martín, Isabel Linares Galiana, Miguel A. Berenguer Frances, Jon Cacicedo, Rut Cañas Cortés, Silvia Comas Anton, Susana Padrones Sánchez, Santiago Bolívar Cuevas, Renate Parry and Ferran Guedea Edo. Int. J. Mol. Sci. 2018, 19, 3963; doi:10.3390/ijms19123963. 


A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies.

Ivison S, Malek M, Garcia RV, Broady R, Halpin A, Richaud M, Brant RF, Wang SI, Goupil M, Guan Q, Ashton P, Warren J, Rajab A, Urschel S, Kumar D, Streitz M, Sawitzki B, Schlickeiser S, Bijl JJ, Wall DA, Delisle JS, West LJ, Brinkman RR, Levings MK. JCI Insight. 2018 Dec 6;3(23). pii: 121867. doi: 10.1172/jci.insight.121867. 


Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers.

James A. Hutchinson, Kilian Weigand, Akinbami Adenugba, Katharina Kronenberg, Jan Haarer, Florian Zeman, Paloma Riquelme, Matthias Hornung, Norbert Ahrens, Hans J. Schlitt, Edward K. Geissler, Jens M. Werner. Front Immunol. 2018; 9: 146. Published online 2018 Feb 7. doi: 10.3389/fimmu.2018.00146.